Steroid receptor profiling of vinclozolin and its primary metabolites

Toxicology and Applied Pharmacology

Volumn 216, Issue 1, 2006, Pages 44-54

  Molina Molina, José Manuel ^a,b   Hillenweck, Anne ^c   Jouanin, Isabelle ^c   Zalko, Daniel ^c   Cravedi, Jean Pierre ^c   Fernández, Mariana Fátima ^b   Pillon, Arnaud ^a   Nicolas, Jean Claude ^a   Olea, Nicolás ^b   Balaguer, Patrick ^a  

^a INSERM   (France)

^b UNIVERSITY OF GRANADA   (Spain)

^c CEMAGREF   (France)

Author keywords

Androgen receptor; Estrogen receptors; Fungicide; Glucocorticoid receptor; Mineralocorticoid receptor; Progesterone receptor; Reporter cell lines; Vinclozolin

Indexed keywords

2 [[(3,5 DICHLOROPHENYL)CARBMOYL]OXY] 2 METHYL 3 BUTENOIC ACID; 3',5' DICHLORO 2 HYDROXY 2 METHYLBUT 3 ENANILIDE; ANDROGEN; ANTIANDROGEN; ANTIESTROGEN; ANTIGESTAGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; FUNGICIDE; GLUCOCORTICOID; HYBRID PROTEIN; LIGAND; LUCIFERASE; MINERALOCORTICOID; MINERALOCORTICOID ANTAGONIST; PROGESTERONE; STEROID RECEPTOR; TRANSCRIPTION FACTOR GAL4; UNCLASSIFIED DRUG; VINCLOZOLIN;

ARTICLE; BINDING AFFINITY; CELL LINE; CHIMERA; COMPARATIVE STUDY; CONTROLLED STUDY; HORMONAL REGULATION; HORMONE ACTION; HORMONE INHIBITION; HUMAN; HUMAN CELL; METABOLITE; RECEPTOR BINDING; REPORTER GENE; RISK ASSESSMENT;

ALDOSTERONE; ANDROGEN ANTAGONISTS; ANDROGEN RECEPTOR ANTAGONISTS; ANILIDES; BINDING, COMPETITIVE; CARBAMATES; CELL LINE, TUMOR; CELL SURVIVAL; DEXAMETHASONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; GENE EXPRESSION; HUMANS; LUCIFERASES; METRIBOLONE; OXAZOLES; PROGESTERONE CONGENERS; PROMEGESTONE; RECEPTORS, ANDROGEN; RECEPTORS, GLUCOCORTICOID; RECEPTORS, MINERALOCORTICOID; RECEPTORS, PROGESTERONE; RECEPTORS, STEROID; TESTOSTERONE CONGENERS; TRITIUM;

ANIMALIA;

EID: 33748754636     PISSN: 0041008X     EISSN: 10960333     Source Type: Journal    
DOI: 10.1016/j.taap.2006.04.005     Document Type: Article

References (64)

1. Andersen H.R., Vinggaard A.N., Rasmussen T., Gjermandsen I.M., and Bonefeld-jorgensen E.C. Effects of currently used pesticides in assays for estrogenicity, androgenicity, and aromatase activity in vitro. Toxicol. Appl. Pharmacol. 179 (2002) 1-12
2. Anway M.D., Cupp A.S., Uzumcu M., and Skinner M.K. Epigenetic transgenerational actions of endocrine disruptors and male fertility. Science 308 (2005) 1466-1469
3. Balaguer P., François P., Comunale F., Fenet H., Boussioux A.M., Pons M., Nicolas J.C., and Casellas C. Reporter cell lines to study the estrogenic effects of xenoestrógenos. Sci. Total Environ. 233 (1999) 47-56
4. Balaguer P., Fenet H., Georget V., Comunale F., Térouanne B., Gilbin R., Gomez E., Boussioux A.M., Sultan C., Pons M., Nicolas J.C., and Casellas C. Reporter cell lines to monitor steroid and antisteroid potential of environmental samples. Ecotoxicology 9 (2000) 105-114
5. Balaguer P., Boussioux A.M., Demirpence E., and Nicolas J.C. Reporter cell lines are useful tools for monitoring biological activity of nuclear receptor ligands. Luminescence 16 (2001) 153-158
6. Baumeister M., Steep M., Dieckmann S., Melzer O., Kloppel H., Jurling H., and Bender L. Transfer of the fungicide vinclozolin from treated to untreated plants via volatilization. Chemosphere 48 (2002) 75-82
7. Colborn T. Environmental estrogens: health implications for humans and wildlife. Environ. Health Perspect. 103 (1995) 135-136
8. Colbert N.K., Pelletier N.C., Cote J.M., Concannon J.B., Jurdak N.A., Minott S.B., and Markowski V.P. Perinatal exposure to low levels of the environmental anti-androgen vinclozolin alters sex-differentiated social play and sexual behaviors in the rat. Environ. Health Perspect. 113 (2005) 700-707
9. Denizot F., and Lang R. Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J. Immunol. Methods 89 (1986) 271-277
10. Diamanti-Kandarakis M.D., Tolis G., and Duleba A.J. Androgens and therapeutic aspects of anti-androgens in women. J. Soc. Gynecol. Investig. 2 (1995) 577-592
11. Fu M., Wang C., Zhang X., and Pestel R. Nuclear receptor modifications and endocrine cell proliferation. J. Steroid Biochem. Mol. Biol. 85 (2003) 133-138
12. Gimeno S., Gerritsen A., Browmer T., and Komen H. Feminization of male carp. Nature 384 (1996) 221-222
13. Graham J.D., and Clarke C.L. Physiological action of progesterone in target tissues. Endocr. Rev. 18 (1997) 502-519
14. Gray Jr. L.E., Ostby J., and Kelce W.R. Developmental effects of an environmental anti-androgen: the fungicide vinclozolin alters sex differentiation of the male rat. Toxicol. Appl. Pharmacol. 129 (1994) 46-52
15. Gray Jr. L.E., Ostby J., Monosson E., and Kelce W.R. Environmental anti-androgens: low doses of the fungicide vinclozolin alter sexual differentiation of the male rat. Toxicol. Ind. Health 15 (1999) 48-64
16. Guo I.C., Wu L.S., Lin J.H., and Chung B.C. Differential inhibition of progesterone synthesis in bovine luteal cells by estrogens and androgens. Life Sci. 68 (2001) 1851-1865
17. Haith D.A., and Rossi F.S. Risk assessment of pesticide runoff from turf. J. Environ. Qual. 32 (2003) 447-455
18. Jensen T.K., Toppari J., Keiding N., and Skakkebaek N.E. Do environmental estrogens contribute to the decline in male reproductive health?. Clin. Chem. 41 (1995) 1896-1901
19. Kelce W.R., Monosson E., Gamcsik M.P., Laws S.C., and Gray Jr. L.E. Environmental hormone disruptors: evidence that vinclozolin developmental toxicity is mediated by anti-androgenic metabolites. Toxicol. Appl. Pharmacol. 126 (1994) 276-285
20. Kelce W.R., Lambright C.R., Gray Jr. L.E., and Roberts K.P. Vinclozolin and p,p-DDE alter androgen-dependent gene expression: in vivo confirmation of an androgen receptor-mediated mechanism. Toxicol. Appl. Pharmacol. 142 (1997) 192-200
21. Kelce W.R., Gray Jr. L.E., and Wilson E.M. Antiandrogens as environmental endocrine disruptors. Reprod. Fertil. 10 (1998) 105-111
22. Kemppainen J.A., and Wilson E.M. Agonist and antagonist activities of hydroxyflutamide and Casodex relate to androgen receptor stabilization. Urology 48 (1996) 157-163
23. Kojima H., Katsura E., Takeuchi S., Niyama K., and Kobayashi K. Screening for estrogen and androgen receptor activities in 200 pesticides by in vitro reporter gene assays using Chinese hamster ovary cells. Environ. Health Perspect. 112 (2004) 524-531
24. Körner W., Vinggaard A.M., Térouanne B., Ma R., Wieloch C., Schlumpf M., Sultan C., and Soto A.M. Interlaboratory comparison of four in vitro assays for assessing androgenic and anti-androgenic activity of environmental chemicals. Environ. Health Perspect. 112 (2004) 695-702
25. Kraus W.L., Weis K.E., and Katzenellenbogen B.S. Inhibitory cross-talk between steroid hormone receptors: differential targeting of estrogen receptor in the repression of its transcriptional activity by agonist- and antagonist-occupied progestin receptors. Mol. Cell. Biol. 15 (1995) 1847-1857
26. Landers J.P., and Spelsberg T.C. Updates and new models for steroid hormone action. Ann. N. Y. Acad. Sci. 637 (1991) 26-55
27. Laws S.C., Carey S.A., Kelce W.R., and Couper R.L. Differential effects of environmental toxicans on steroid receptor binding. Toxicologist 15 (1995) 294
28. Laws S.C., Carey S.A., Kelce W.R., Cooper R.L., and Gray Jr. L.E. Vinclozolin does not alter progesterone receptor (PR) function in vivo despite inhibition of PR binding by its metabolites in vitro. Toxicology 112 (1996) 173-182
29. Lemaire G., Terouanne B., Mauvais P., Michel S., and Rahmani R. Effect of organochlorine pesticides on human androgen receptor activation in vitro. Toxicol. Appl. Pharmacol. 196 (2004) 235-246
30. Monosson E., Kelce W.R., Lambright C., Ostby J., and Gray Jr. L.E. Peripubertal exposure to the anti-androgenic fungicide, vinclozolin, delays puberty, inhibits the development of androgen-dependent tissues, and alters androgen receptor function in the male rat. Toxicol. Ind. Health 15 (1999) 65-79
31. Nellemann C., Dalgaard M., Lam H.R., and Vinggaard A.M. The combined effects of vinclozolin and procymidone do not deviate from expected additivity in vitro and in vivo. Toxicol. Sci. 71 (2003) 251-262
32. Nuclear Receptors Nomenclature Committee. A unified nomenclature system for the nuclear receptor superfamily. Cell 97 (1999) 161-163
33. Oelkers W.H. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy. Climacteric 8 (2005) 19-27
34. Oliva A., Miami A., and Multigner L. Environmental agents and erectile dysfunction: a study in a consulting population. J. Androl. 23 (2002) 546-550
35. Papadopoulou-Mourkidou E. Postharvest-applied agrochemicals and their residues in fresh fruits and vegetables. J. Assoc. Off. Anal. Chem. 74 (1991) 745-765
36. Paris F., Balaguer P., Terouanne B., Servant N., Lacoste C., Cravedi J.P., Nicolas J.C., and Sultan C. Phenylphenols, biphenols, bisphenol-A and 4-tert-octylphenol exhibit alpha and beta estrogen activities and anti-androgen activity in reporter cell lines. Mol. Cell Endocrinol. 193 (2002) 43-49
37. Pickford D.B., and Morris I.D. Effects of endocrine-disrupting contaminants on amphibian oogenesis: methoxychlor inhibits progesterone-induced maturation of Xenopus laevis oocytes in vitro. Environ. Health Perspect. 107 (1999) 285-292
38. Pillon A., Servant N., Vignon F., Balaguer P., and Nicolas J.C. In vivo bioluminescence imaging to evaluate estrogenic activities of endocrine disrupters. Anal. Biochem. 340 (2005) 295-302
39. Rose P.G. Endometrial carcinoma. N. Engl. J. Med. 335 (1996) 640-649
40. Scippo M.L., Argiris C., Van de Weerdt C., Muller M., Willemsen P., Martial J., and Maghuin-Rogister G. Recombinant human estrogen, androgen and progesterone receptors for detection of potential endocrine disruptors. Anal. Bioanal. Chem. 378 (2004) 664-669
41. Seimandi M., Lemaire G., Pillon A., Perrin A., Carlavan I., Voegel J.J., Vignon F., Nicolas J.C., and Balaguer P. Differential responses of PPARα, PPARδ and PPARγ reporter cell lines to selective PPAR synthetic ligands. Anal. Biochem. 344 (2005) 8-15
42. Sohoni P., and Sumpter J.P. Several environmental oestrogens are also anti-androgens. J. Endocrinol. 158 (1998) 327-339
43. Sonnenschein C., and Soto A.M. An updated review of environmental estrogen and androgen mimics and antagonists. J. Steroid Biochem. Mol. Biol. 65 (1998) 143-150
44. Sonneveld E., Jansen H.J., Riteco J.A., Brouwer A., and van der Burg B. Development of androgen- and estrogen-responsive bioassays, members of a panel of human cell line-based highly selective steroid-responsive bioassays. Toxicol. Sci. 83 (2005) 133-148
45. Spencer E.Y. Guide to the Chemicals Used in Crop Protection. 7th edn. (1982), Publication 1043, Agriculture Canada Research Branch, Ottawa, Canada KIA OS9 585
46. Sultan C., Balaguer P., Terouanne B., Georget V., Paris F., Jeandel C., Lumbroso S., and Nicolas J. Environmental xenoestrogens, anti-androgens and disorders of male sexual differentiation. Mol. Cell. Endocrinol. 178 (2001) 99-105
47. Szeto S.Y., Burlinson N.Y., Rettig S.J., and Trotter J. Identification of hydrolysis products of the fungicide vinclozolin by spectroscopic and X-ray crystallographic methods. J. Agric. Food Chem. 37 (1989) 1103-1108
48. Terouanne B., Tahiri B., Georget V., Belon C., Poujol N., Avances C., Orio F.J., Balaguer P., and Sultan C. A stable prostatic bioluminescent cell line to investigate androgen and anti-androgen effects. Mol. Cell. Endocrinol. 160 (2000) 39-49
49. Terouanne B., Paris F., Servant N., Georget V., and Sultan C. Evidence that chlormadinone acetate exhibits antiandrogenic activity in androgen-dependent cell line. Mol. Cell. Endocrinol. 198 (2002) 143-147
50. Tran D.Q., Klotz D.M., Ladlie B.L., Ide C.F., McLachlan J.A., and Arnold S.F. Inhibition of progesterone receptor activity in yeast by synthetic chemicals. Biochem. Biophys. Res. Commun. 229 (1996) 518-523
51. Tsai M.J., and O'Malley B.W. Molecular mechanisms of action of steroid/thyroid receptor superfamily members. Annu. Rev. Biochem. 63 (1994) 451-486
52. U.S. EPA. Vinclozolin; notice of filing a pesticide petition to establish a tolerance for a certain pesticide chemical in or on food. Fed. Regist. 68 (2003) 14628-14635. http://www.epa.gov/fedrgstr/EPA-PEST/2003/March/Day-26/p7246 Available:http://www.epa.gov/fedrgstr/EPA-PEST/2003/March/Day-26/p7246
53. Uzumcu M., Suzuki H., and Skinner M.K. Effect of the anti-androgenic endocrine disruptor vinclozolin on embryonic testis cord formation and postnatal testis development and function. Reprod. Toxicol. 18 (2004) 765-774
54. Vinggaard A.M., Joergensen E.C.B., and Larsen J.C. Rapid and sensitive reporter gene assays for detection of antiandrogenic and estrogenic effects of environmental chemicals. Toxicol. Appl. Pharmacol. 155 (1999) 150-160
55. Vonier P.M., Crain D.A., McLachlan J.A., Guillette L.J., and Arnold S.F. Interaction of environmental chemicals with the estrogen and progesterone receptors from the oviduct of the American alligator. Environ. Health Perspect. 104 (1996) 1318-1322
56. White W.B., Pitt B., Preston R.A., and Hanes V. Antihypertensive effects of drospirenone with 17beta-estradiol, a novel hormone treatment in postmenopausal women with stage 1 hypertension. Circulation 112 (2005) 1979-1984
57. Webster N., Jin J.R., Green S., Hollis M., and Chambon P. The yeast UASG is a transcriptional enhancer in human HeLa cells in the presence of the GAL4 trans-activator. Cell 52 (1998) 169-178
58. Willemsen P., Scippo M.L., Kausel G., Figueroa J., Maghuin-Rogister G., Martial J.A., and Muller M. Use of reporter cell lines for detection of endocrine-disrupter activity. Anal. Bioanal. Chem. 378 (2004) 655-663
59. Wilson V.S., Bobseine K.L., Lambright C.R., and Gray Jr. L.E. A novel cell line, MDA-kb2 that stably expresses an androgen and glucocorticoid responsive reporter for the detection of hormone receptor agonists and antagonists. Toxicol. Sci. 66 (2002) 69-81
60. Wolf C.J., LeBlanc G.A., Ostby J.S., and Gray Jr. L.E. Characterization of the period of sensitivity of fetal male sexual development to vinclozolin. Toxicol. Sci. 55 (2000) 152-161
61. Wong C., Kelce W.R., Sar M., and Wilson E.M. Androgen receptor antagonist versus agonist activities of the fungicide vinclozolin relative to hydroxyflutamide. J. Biol. Chem. 270 (1995) 19998-20003
62. Yu W.J., Lee B.J., Nam S.Y., Ahn B., Hong J.D., Do J.C., Kim Y.C., Lee Y.S., and Yum Y.W. Reproductive disorders in pubertal and adult phase of the male rats exposed to vinclozolin during puberty. J. Vet. Med. Sci. 66 (2004) 847-853
63. Zhu X.D., Bonet B., and Knopp R.H. Estradiol 17h inhibition of LDL oxidation and endothelial cell cytotoxicity is opposed by progestins to different degrees. Atherosclerosis 148 (2000) 31-41
64. Zober A., Hoffmann G., Ott M.G., Will W., Germann C., and van Ravenzwaay B. Study of morbidity of personnel with potential exposure to vinclozolin. Occup. Environ. Med. 52 (1995) 233-241